Chronic median nerve modulation reduces ventricular arrhythmia and improves ventricular function in a postmyocardial...

Area of Science:

• Cardiology
• Neuromodulation
• Medical Research

Background:

• Ventricular arrhythmia and dysfunction are significant complications following myocardial infarction (MI).
• Median nerve stimulation (MNS) is an emerging neuromodulation technique with potential therapeutic applications.
• The chronic effects of MNS on post-MI cardiac complications remain largely unexplored.

Purpose of the Study:

• To investigate the impact of chronic MNS on ventricular arrhythmia and ventricular dysfunction in a rabbit model of post-MI.
• To evaluate the underlying mechanisms, including effects on cardiac sympathetic activity and inflammatory markers.

Main Methods:

• Following MI, rabbits were randomized into control and MNS groups for 2 weeks of chronic MNS.
• Assessment included ventricular function (ejection fraction), arrhythmias (PVCs, VT), cardiac sympathetic nerve density, circulating norepinephrine (NE), and interleukin-1 β (IL-1 β) levels.

Main Results:

• The MNS group exhibited significantly fewer premature ventricular complexes and episodes of ventricular tachycardia compared to the control group.
• Chronic MNS reduced cardiac sympathetic nerve density and circulating NE levels.
• MNS improved left ventricular ejection fraction and decreased serum IL-1 β levels.

Conclusions:

• Chronic MNS demonstrates a protective effect against ventricular arrhythmia and improves ventricular function post-MI.
• These benefits are potentially mediated by the suppression of cardiac sympathetic activity and anti-inflammatory actions.
• MNS represents a promising therapeutic strategy for managing post-MI cardiac complications.